RSS-Feed abonnieren
DOI: 10.1055/s-2000-13458
MANAGEMENT OF THE INFANT BORN TO A MOTHER INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1): CURRENT CONCEPTS
Publikationsverlauf
Publikationsdatum:
31. Dezember 2000 (online)
![](https://www.thieme-connect.de/media/ajp/200008/lookinside/thumbnails/10.1055-s-2000-13458-1.jpg)
ABSTRACT
Despite the use of highly active antiretroviral therapy (HAART) and the success of protocol PACTG-076 in decreasing perinatal transmission of HIV infection in many industrialized countries, a total of 5,600,000 new cases of HIV infection were diagnosed worldwide in 1999. Of those cases, more than 10% are children under 15 years of age. The vast majority of pediatric HIV infection is due to perinatal transmission. More than 95% of HIV-infected people live in the developing world. Different studies are currently being conducted with modifications of the original PACTG-076, especially shorter courses of zidovudine (ZDV), combinations of antiretrovirals (ZDV and 3TC), or comparison of a modified version of the standard ZDV course vs. a single dose of nevirapine for the mother intrapartum and also for the newborn. The results of these studies may provide more affordable, alternative regimens to prevent maternal-to-child HIV-1 transmission for developing countries than the PACTG-076 protocol. It is very important that physicians and physician extenders (nurse practitioners and physician assistants) caring for infants born to HIV-infected mothers have an understanding of the pathophysiology of vertical HIV-1 infection transmission. They should be familiar with the conditions associated with an increased risk of transmission, interventions available to decrease this risk, current medications, and laboratory resources.
KEYWORD
Pediatric HIV infection - pediatric AIDS - perinatal transmission of HIV
REFERENCES
- 1 AIDS Epidemic Update, December. WHO/UNAIDS 1999
- 2 Pape J W, Deschamps M M, Verdier R I. The urge for an AIDS vaccine: perspectives from a developing country. AIDS Res Hum Retroviruses . 1992; 8 1535-1537
- 3 Peckham C, Gibb D. Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med . 1995; 333 298-302
- 4 Wilfert C M. Perinatal HIV transmission-a global-problem: controversy and protection of the next generation. Semin Pediatr Infect Dis . 1998; 9 339-344
- 5 Johann-Liang R, Cervia J S, Noel G J. Characteristics of human immunodeficiency virus-infected children at the time of death: an experience in the 1990s. Pediatr Infect Dis J . 1997; 16 1145-1150
- 6 The Working Group on Mother-to-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retroviral . 1995; 8 506-510
- 7 The European Collaborative Study. Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS . 1996; 10 1675-1681
- 8 Burns D N, Landesman S, Muenz L R. Cigarette smoking, premature rupture of membranes, and vertical transmission of HIV-1 among women with low CD4+ levels. J Acquir Immune Defic Syndr . 1994; 7 718-726
- 9 Hengel R L, Kennedy M S, Steketee R W. Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses . 1998; 14 475-481
- 10 Pelliccia P, Galli L, de Martino M. Lack of mother-to-child HIV-1 transmission is associated with elevated serum levels of 90 K immune modulatory protein. AIDS . 2000; 14 F41-F45
- 11 Mofenson L M, Lambert J S, Stiehm E R. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Engl J Med . 1999; 341 385-393
- 12 Soeiro R, Rubinstein A, Rashbaum W K, Lyman W D. Materno-fetal transmission of AIDS: frequency of HIV-1 nucleic acid sequences in human fetal DNA. J Infect Dis . 1992; 166 699-703
- 13 De Andreis C, Simoni G, Rossella F. HIV-1 proviral DNA polymerase chain reaction detection in chorionic villi after exclusion of maternal contamination by variable number of tandem repeats analysis. AIDS . 1996; 10 711-715
- 14 Dunn D T, Brandt C D, Krivine A. The sensitivity of HIV-1-DNA PCR in the neonate period and the relative contributions of intrauterine and intrapartum transmission. AIDS . 1995; 9 F7-F11
- 15 Brossard Y, Aubin J-T, Mandelbrot L. Frequency of early in utero HIV-1 infection: a blind DNA polymerase chain reaction study on 100 fetal thymuses. AIDS . 1995; 9 359-366
- 16 Ehrnst A, Lindgren S, Dictor M. HIV in pregnant women and their offspring: evidence for late transmission. Lancet . 1991; 338 203-207
- 17 Shearer W, Quinn T C, LaRussa P. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. N Engl J Med . 1997; 336 1337-1342
- 18 Galli L, de Martino M, Tovo P-A. Onset of clinical signs in children with HIV-1 perinatal infection. AIDS . 1995; 9 455-461
- 19 Bryson Y J. Perinatal HIV-1 transmission: recent advances and therapeutic interventions. AIDS . 1996; 33-42 (33-42)
- 20 Henin Y, Mandelbrot L, Henrion R, Pradinaud R, Coulaud J P, Montagnier L. Virus excretion in the cervicovaginal secretions of pregnant and non-pregnant women. J Acquir Immune Defic Syndr . 1993; 6 72-75
- 21 Goedert J J, Duliege A M, Amos C I, Felton S, Biggar R J, and The International Registry of HIV-exposed Twins. High risk of HIV-1 infection for first-born twins. Lancet . 1991; 338 1471-1475
- 22 Biggar R J, Miotti P G, Taha T E. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet . 1996; 347 1647-1650
- 23 Mandelbrot L, Mayaux M J, Bongain A. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort. Am J Obstet Gynecol . 1996; 175 661-667
- 24 Minkoff H, Burns D, Landesman S. The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol . 1995; 173 585-589
- 25 Nielsen K, Boyer P, Dillon M. Presence of human immunodeficiency virus (HIV) type 1 and HIV-1 specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infants. J Infect Dis . 1996; 173 1001-1004
- 26 Boyer P J, Dillon M, Navaie M. Factors predictive of maternal-fetal transmission of HIV-1: preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA . 1994; 271 1925-1930
- 27 Landesman S H, Kalish L, Burns D N. Obstetrical factors and the transmission of HIV type 1 from mother to child-WITS. N Engl J Med . 1996; 334 1617-1623
- 28 Committee Opinion. Scheduled Cesarean Delivery and the Prevention of Vertical Transmission of HIV Infection. Committee on Obstetric Practice, American Academy of Obstetrics & Gynecology, Washington, DC, August 1999.
- 29 Van de Perre P. Transmission of human immunodeficiency virus type 1 through breast-feeding: how can it be prevented?. J Infect Dis . 1999; S405-S407 ( S405-S407)
- 30 Dabis F, Leroy V, Castetbon K, Spira R, Newell M-L, Salamon R. Preventing mother-to-chlid transmission of HIV-1 in Africa in the year 2000. AIDS . 2000; 14 1017-1026
- 31 Tess B T, Rodrigues L C, Newell M L. Sao Paolo Collaborative Study of Vertical Transmission of HIV-1. Breastfeeding among HIV-infected women in Sao Paolo State, Brazil. Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. Washington, DC, September 1997 (abstract, p. 14)
- 32 Dunn D T, Newell M L, Ades A E, Peckham C S. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet . 1992; 340 585-588
- 33 De Martino M, Tovo P-A, Tozzi A E. HIV-1 transmission through breastmilk: appraisal of risk according to duration of feeding. AIDS . 1992; 6 991-997
- 34 McNeeley D F, Laroche L, Bhutra S, Suarez E, Rao S, Rajegowda B. Newborn screening for human immunodeficiency virus infection in the Bronx, NY, and evolving public health policy. Am J Perinatol . 1999; 16 503-507
- 35 CDC. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. MMWR . 1998; 47(No. RR-2) 1-30
- 36 Connor E M, Sperling R S, Gelber R, for the Pediatric AIDS Clinical Trials Group Protocol 076 Group. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med . 1994; 331 1173-1180
- 37 Sperling R S, Shapiro D E, Coombs R W, for the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med . 1996; 335 1621-1629
- 38 O'Sullivan M J, Boyer P J, Scott G B. The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with HIV and their infants: phase I ACTG 082. ZDV Collaborative Working Group. Am J Gynecol . 1992; 168 1516-1519
- 39 Wade N A, Birkhead G S, Warren B L. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med . 1998; 39 1409-1414
- 40 Culnane M, Fowler M G, Lee S S, for the Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. JAMA . 1999; 281 151-157
- 41 World Health Organization. Recommendations on the safe and effective use of short-course ZDV for prevention of mother-to-child transmission of HIV. Wkly Epidemiol Rec . 1998; 73 313-314
- 42 Guay L A, Musoke P, Fleming T. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet . 1999; 354 795-802
- 43 Saba J. The results of the PETRA intervention trial to prevent perinatal transmission in SubSaharan Africa. In: Program and abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago, January 31-February 4, 1999. Abstract 57
- 44 Dabis F, Leroy V. Preventing mother-to-child transmission of HIV: practical strategies for developing countries. AIDS Reader . 2000; 10 241-244
- 45 Andiman W A. Medical management of the pregnant woman infected with human immunodeficiency virus type 1 and her child. Semin Perinatol . 1998; 22 72-86
- 46 Oleske J, Scott G B, and the Working Group on Antiretroviral Therapy and Medical Management of Infants, Children, and Adolescents with HIV Infection. Antiretroviral therapy and medical management of pediatric HIV infection and 1997 USPHS/IDSA report on the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Pediatrics . 1998; 1005-1085 (1005-1085)
- 47 Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report . 1996; 8 1-39
- 48 Rodriguez E M, Diaz C, Fowler M G. The clinical management of children perinatally exposed to HIV. Prim Care . 1997; 24 643-666
- 49 Nelson J D, McCracken Jr H G. AIDS and breastfeeding. Pediatri Infect Dis J. 1998; 17. Newsletter
- 50 Newell M L. Mechanisms and timing of maternal-to-child transmission of HIV-1. AIDS . 1998; 12 831-836
- 51 Bulterys M, Lepage P. Mother-to-child transmission of HIV. Curr Opin Pediatr . 1998; 10 143-150